Lazanda
® (
fentanyl nasal spray) is a prescription narcotic pain medication approved for the treatment of breakthrough cancer pain. Breakthrough pain is defined as intense flares of pain that "break through" regular, around-the-clock pain medication. Lazanda should only be used by people who have already been taking, and are tolerant to, regularly scheduled narcotic medication for their underlying cancer pain.
Lazanda contains
fentanyl, a potent opioid pain medication. Like other medications that contain fentanyl, Lazanda is a Schedule II
controlled substance. This means there are strict laws and regulations controlling the use of the medication. Schedule II controlled substances are considered to have the highest abuse potential of all prescription medications.
Because of the potential for abuse and possible overdose, this medication is only available through a restricted program called the Lazanda Risk Evaluation and Mitigation Strategy (REMS) program. You, your healthcare provider, and your pharmacy must be enrolled in this program.
Your healthcare provider will discuss the program with you, give you an opportunity to ask questions, and ask you to sign a "Patient-Prescriber Agreement." The pharmacy will enroll you in the program the first time you fill your Lazanda prescription.
HealthSavvy Sign In
|
